Matthew Truesdale, MD, FACS, discusses validation data showing that IsoPSA improves risk stratification for clinically significant prostate cancer in men with elevated PSA both with and without pre-biopsy mpMRI.
Advanced Urology Institute
Latest Content
Scott B. Sellinger, MD, FACS, discusses the challenges facing urologists, the loss of telehealth flexibility, and why bipartisan action remains urgent.
Martin B. Richman, MD, MBA, FACS, outlines recent advancements in BPH, with an emphasis on the importance of a patient-focused approach to care.
“Private equity allows an opportunity to provide improved scale with large organization,” says Scott B. Sellinger, MD, FACS.
Advertisement
Advertisement
Trending on Urology Times
1
KEYNOTE-B15 data on enfortumab vedotin plus pembrolizumab in MIBC published in NEJM
2
FDA grants priority review to talazoparib plus enzalutamide for HRR gene-altered mCSPC
3
Can Aydogdu, MD on using ctDNA to predict nodal metastases at cystectomy
4
FDA grants tentative approval to generic olaparib tablets across previously approved indications
5